NSEOutcome of Board Meeting6d ago · 12 Aug 2026, 06:13 pm

Outcome of Board Meeting

Natural Capsules Limited · NATCAPSUQ

✦ AI SummaryResults

Natural Capsules Limited has submitted its financial results for the period ended June 30, 2026. The company's board of directors has approved the unaudited consolidated and standalone financial results. Additionally, the board has approved a preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to the promoter/promoter group at an issue price of ₹160 per equity share.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natural Capsules Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

Attachments (1)

📄

NCL1993_12082026181248_Outcome_of_BM_and_Financial_Results_for_June_30_2026.pdf

pdf

Download →
View document text
cN flfl PI SU UH Lfl ' Q91 qu5 :2015 i0 r0 o1 e: n2 t0 a1 l5 ) Robt ), \)\ORSAE CA K &’A‘ L Management / Management /. brapers ACEREDITED o CORP & REGD OFFICE : “ TRIDENT TOWERS” No. 23. 4th Floor, 100 feet Road. agar 2nd Block, Bangalore-560011 Phone : 080-26561562 / 1571 /1573 /581 URL : www.naturalcapsules.com Email : infot@naturalcapsules.com. CIN No. : L85 110KA1993PLCO14742 Date: August 12, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai — 400001 Mumbai — 400051 Scrip Code: 524654 Subject: Outcome of the Board Meeting held on Wednesday August 12, 2026. This is to inform you that the Board of Directors at their meeting held on Wednesday August 12, 2026, have: 1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30, 2026. 2. Preferential issue of warrants: a. The Preferential Issue of up to 1,25,000 ( One Lakh Twenty Five Thousand Only) Equity Shares of Face Value of %10/- each ( Rupees Ten Only) to the person(s) belonging to the promoter /promoter group at an issue price of I160 (Rupees One Hundred Sixty Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018, subject to the approval of members in the General Meeting and other statutory and regulatory approvals whereas necessary and applicable. Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January, 2026, is enclosed as Annexure A. b. The issuance of 5,00,000 (Five Lakh only) Convertible Warrants each convertible into, 1 (one) fully paid-up equity share of the Company of face value of I10/- each ( Rupees Ten Only) to the person(s) belonging to the promoter/promoter group of the company, on a preferential basis (* Preferential Issue”) at an issue price of 160/~ ( Rupees One Hundred Sixty Only) price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018, Minimum amount of I40/- (Rupees Fourty Only) which is equivalent to 25% of warrant Issue Price shall be paid at the time of subscription and allotment of each warrant, Further subject to the approval of members in the General Meeting and other statutory and regulatory approvals whereas necessary and applicable. Further, the details as required under Regulation 30 of the Listing Regulations, 2015 read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January, 2026, is enclosed as Annexure A. 3. Considered and approved the draft Notice of Extra Ordinary General Meeting of the Members of the Company scheduled to be held on Wednesday, 9" September, 2026, at the registered office of the company the relevant details will be submitted to the Stock Exchange in due course of time. 4. The Board of Directors has appointed M/S Deepak Sadhu, Practicing Company Secretaries (COP: 14992), as the Scrutinizer to the E-voting Process. The Board Meeting commenced at 3:30 PM and concluded at 6:00 PM. Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Yours Faithfully, For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481 - 1: Plot No. 7A2, KIADB Industrial Area, Attibele-362 107, Bangalore. Tel : 08110-643068, Fax : 080-27820325 I1: R.S. No. 84, Perambai Road, Pitchaiveeranpet, Pondicherry - 605 010. Tel : 0413-2290833, Fax : 0413-2293251 NHTUHHL 150 150 e F\l)\OeSE N< c fl P S U Le s Q9qu0a0l1ky :2015 e}n1v4i0r0o1nm e:n2t0a1l5 ] ey" +% -o i Management// Management // Hiah &55fe F L %, & e g gy LIMITGD VG - Caps CORP & REGD OFFICE : “ TRIDENT TOWERS” No. 23. 4th Floor, 100 feet Road. 2nd Block, Bangalore-560011 Phone : 080-26561562 / 1571 /1573 /581 URL : www.naturalcapsules.com Email : info@naturals capsules.com. CIN No. : LRSTT0KAT1993PLC0O14742 Annexure-A The details as required to be disclosed under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Ci rcular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026: Sl | Particulars Remarks 1. Type of 1. Equity Shares of face value 310/- each Securities proposed to be 2. Warrants convertible into Equity Shares of face value 310/- each i.e. 1 Equity issued (viz., Share per 1 Warrant. equity shares, convertibles etc.) 2. Type of Issuance | Preferential issuance under Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 3. Total number of 1. 1,25,000 Equity Shares at issue price of ¥160/- per Equity Share aggregating to securities 2 crore to the persons belonging to Promoter/Promoter Group category. proposed to be issued or the 2. 5,00,000 Warrants, convertible into equivalent number of equity shares at an total amount for issue price of I160/- per Equity Share (“Warrant Exercise Price”) aggregating to which the 8 crore to the persons belonging to Promoter/Promoter Group category. securities will be issued (approximately) 4. Additional details in case of preferential issue 4A. |Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) — 1,25.000 Equity Shares. Investors - EQUITY 4B. | Name of the 1. Mr. Sunil L Mundra (Promoter/Promoter Group) — 5.00,000 Warrants, Investors - convertible into equivalent number of equity shares. CONVERTIBLE WARRANTS 4C. | Post allotment of || Particulars Pre-Preferential Allotment | *Post-Preferential Allotment securities - outcome of the No. of shares | %held No. of | %held subscription, held shares held issue price / Promoter/Promoter Group Category allotted price (in || Mr. Sunil L |6.02.290 5.79% 12,27.290 11.12% case of | | Mundra convertibles), *Assuming full conversion of Warrants into equity shares number of investors. The post issue shareholding pattern has been prepared with shareholding as on 10th August, 2026, on the basis that the proposed allottees would have subscribed to all the warrants and have been allotted all the equity shares upon conversion of warrants. %160/- per Equity Share price determined as per the SEBI (Issue of Capital and Disclosure Requirements) Regulation, 2018 Unit - I : Plot No. 7A2, KIADB Industrial Area, Attibele-362 107, Bangalore. Tel : 08110-645068, Fa : 080-27820325 Unit- I1: R.S. No. 84, Perambai Road, Pitchaiveeranpet, Pondicherry - 605 010. Tel : 0413-2290833, Fax 1 0413-2293251 0SE Cap 150 150 e & AR 9001 :2015 )14001 :2015 | i Qqualky environmental ey % Management/ Management /) Hronaperers AC R 5 . CORP& REGD OFFICE “ TRIDENT TOWERS” No. 23. 4th Floor, 100 et Road. 2nd Block, Bangalore-560011 Phone : 08! 0-26561562/ 1571 /1573 /581 URL : www.naturalcapsules.com Email : info(@natural om, CIN No. : LRS1T0KA1993PLCO14742 4D. |Issue Price — | I160/- ( Rupees One Hundred Sixty Only) Price determined as per the SEBI (Issue of Equity & | Capital and Disclosure Requirements) Regulations, 2018 Convertibles ‘Warrants 4E. |In case of | Each Warrant would be convertible into one equity share and the rights attached to the convertibles - | Warrants can be exercised at any time within a period of 18 (Eighteen) months from the intimation on | date of allotment of Warrants. conversion of | An amount equivalent to 25% of the Warrant Exercise Price shall be payable at the time securities or on | of subscription and allotment of each Warrant and the balance 75% of the Warrant lapse of the | Exercise Price shall be payable by the Warrant holder against each Warrant at the time of tenure of the | allotment of Equity Shares pursuant to exercise of the options attached to Warrant(s) to instrument subscribe to the Equity Share(s). The amount paid against Warrants shall be adjusted/ set-off against the issue price for the resultant Equity Shares. In case the Warrant holder fails to exercise the Warrant within a period of 18 months from date of allotment of Warrant, the [Showing first 8,000 characters — download PDF for full document]